DPD Quantification in Cardiac Amyloidosis: A Novel Imaging Biomarker

Current diagnostic protocols for transthyretin-related cardiac amyloidosis rely heavily on planar bone scintigraphy. This imaging modality often lacks the precision required for detailed quantification of amyloid deposition within the heart. Standard visual grading systems provide qualitative assessments but fail to capture the full spectrum of disease progression. No prior work had resolved the limitations associated with soft tissue interference during these scans. That uncertainty drove the investigation into three-dimensional imaging alternatives. Single-photon emission computed tomography offers a potential solution for volumetric analysis of cardiac uptake. This gap motivated researchers to explore whether advanced computational metrics could enhance diagnostic sensitivity. The clinical community requires robust tools to track changes in amyloid burden over time.

The primary aim of this study was to determine if volumetric quantification of bone scintigraphy improves diagnostic accuracy for cardiac amyloidosis. Researchers sought to establish a more precise method for quantifying amyloid burden compared to traditional planar imaging. The study addressed the limitations of current visual grading systems that rely on two-dimensional representations. Investigators hypothesized that three-dimensional data could provide a more granular assessment of disease severity. This work was motivated by the need to overcome soft tissue interference that complicates the interpretation of advanced disease stages. The team aimed to develop a composite metric that remains sensitive across the full range of Perugini grades. By comparing volumetric data with myocardial extracellular volume, the authors intended to validate the clinical utility of their proposed biomarkers. This research provides a framework for moving beyond qualitative visual assessments in nuclear cardiology.

This retrospective analysis examined one hundred patient scans to evaluate quantitative imaging parameters. The research team utilized single-photon emission computed tomography combined with computed tomography for all volumetric assessments. Investigators recorded peak standardized uptake values from the heart, adjacent vertebrae, and paraspinal muscles. They calculated a composite retention index to normalize cardiac uptake against surrounding tissue signals. The study compared these new volumetric metrics against traditional planar heart-to-lung retention ratios. A subset of participants underwent myocardial extracellular volume assessment via computed tomography for validation purposes. The review approach focused on correlating these quantitative values with established Perugini visual grades. Statistical analysis determined the diagnostic accuracy and performance of each metric across the patient cohort.

The composite SUV retention index demonstrated superior performance by increasing consistently across all Perugini grades. Cardiac SUVpeak values showed a significant plateau between grade 2 and grade 3, limiting their utility in advanced cases. The study reported an excellent diagnostic accuracy with an area under the curve of 0.999 for both the cardiac SUVpeak and the composite index. Conventional planar heart-to-lung ratios achieved a slightly lower diagnostic accuracy with an area under the curve of 0.987. Paraspinal muscle uptake values exhibited a significant increase as the disease grade progressed. Conversely, vertebral uptake values showed a significant decrease as the severity of amyloidosis increased. The cardiac SUVpeak displayed a strong correlation with myocardial extracellular volume measurements, with an r-squared value of 0.73. These findings suggest that volumetric quantification outperforms standard planar techniques for assessing cardiac amyloid burden.

The authors propose that three-dimensional quantification of bone scintigraphy significantly improves diagnostic precision. This approach effectively surpasses the limitations inherent in traditional two-dimensional planar imaging methods. The researchers suggest that the composite retention index successfully resolves the plateau effect observed in simple cardiac uptake measurements. This metric allows for a clearer distinction between advanced disease stages that were previously difficult to differentiate. The study indicates that these quantitative parameters correlate strongly with established markers of myocardial extracellular volume. These findings imply that such metrics could serve as reliable tools for monitoring therapeutic efficacy in clinical settings. The evidence supports the integration of volumetric analysis into routine diagnostic workflows for cardiac amyloidosis. Future clinical applications may benefit from the standardized use of these advanced imaging indices.